Primary |
Alpha-1 Anti-trypsin Deficiency |
92.4% |
Drug Use For Unknown Indication |
1.7% |
Alpha-1 Anti-trypsin |
1.2% |
Emphysema |
1.2% |
Accidental Exposure |
0.6% |
Idiopathic Thrombocytopenic Purpura |
0.6% |
Panniculitis |
0.6% |
Product Used For Unknown Indication |
0.6% |
Pruritus |
0.6% |
Rash |
0.6% |
|
Urticaria |
17.1% |
Pyrexia |
10.5% |
Infusion Related Reaction |
6.6% |
White Blood Cell Count Decreased |
6.6% |
Fatigue |
5.3% |
Rash |
5.3% |
Anaphylactic Reaction |
3.9% |
Drug Hypersensitivity |
3.9% |
Dyspnoea |
3.9% |
Influenza Like Illness |
3.9% |
Tachycardia |
3.9% |
Tachypnoea |
3.9% |
Throat Tightness |
3.9% |
Tremor |
3.9% |
Weight Increased |
3.9% |
Alpha-1 Anti-trypsin Deficiency |
2.6% |
Chest Discomfort |
2.6% |
Headache |
2.6% |
Migraine |
2.6% |
Nausea |
2.6% |
|
Secondary |
Alpha-1 Anti-trypsin Deficiency |
80.0% |
Product Used For Unknown Indication |
10.0% |
Emphysema |
5.0% |
Rheumatoid Arthritis |
5.0% |
|
Dyspnoea Exertional |
7.1% |
Infusion Site Extravasation |
7.1% |
Lung Infection |
7.1% |
Nausea |
7.1% |
Postmenopausal Haemorrhage |
7.1% |
Rash Macular |
7.1% |
Rash Maculo-papular |
7.1% |
Respiratory Tract Infection |
7.1% |
Sinus Arrest |
7.1% |
Tachypnoea |
7.1% |
Unevaluable Event |
7.1% |
Upper Respiratory Tract Infection |
7.1% |
Venous Thrombosis Limb |
7.1% |
Weight Increased |
7.1% |
|
Concomitant |
Alpha-1 Anti-trypsin Deficiency |
54.3% |
Osteoporosis |
6.5% |
Asthma |
4.3% |
Chronic Obstructive Pulmonary Disease |
4.3% |
Coccidioidomycosis |
4.3% |
Smoking Cessation Therapy |
4.3% |
Benign Prostatic Hyperplasia |
2.2% |
Blood Cholesterol Abnormal |
2.2% |
Bronchiectasis |
2.2% |
Gastritis |
2.2% |
Hypothyroidism |
2.2% |
Lower Respiratory Tract Inflammation |
2.2% |
Nicotine Dependence |
2.2% |
Pain |
2.2% |
Panniculitis |
2.2% |
Pulmonary Arterial Hypertension |
2.2% |
|
Dyspnoea |
11.1% |
Infusion Related Reaction |
7.4% |
Pyrexia |
7.4% |
Retching |
7.4% |
Viral Infection |
7.4% |
Weight Increased |
7.4% |
Anxiety |
3.7% |
Contusion |
3.7% |
Diarrhoea |
3.7% |
Dizziness |
3.7% |
Dyspnoea Exertional |
3.7% |
Hypoaesthesia |
3.7% |
Incorrect Drug Administration Rate |
3.7% |
Influenza Like Illness |
3.7% |
Infusion Site Pain |
3.7% |
Intentional Drug Misuse |
3.7% |
Muscle Spasms |
3.7% |
Myalgia |
3.7% |
Oesophageal Pain |
3.7% |
Rash |
3.7% |
|